David Young - Insider Trading & Ownership

Location
8850 Stanford Boulevard, Suite 2500, Columbia, MD
Summary
The estimated net worth of David Young is at least $101K dollars as of October 3, 2025. David Young is the Pres. Research & Development, Director of Processa Pharmaceuticals, Inc. and owns shares of Processa Pharmaceuticals, Inc. (PCSA) stock worth about $101K.
Signature
/s/ David Young by John J. Wolfel, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of David Young

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PCSA Processa Pharmaceuticals, Inc. Pres. Research & Development, Director $101K Oct 1, 2025

Insider Transactions Reported by David Young:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.